Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Baird Medical Investment Holdings Limited, Common Stock

BDMD

NAQ

$1.83

-$0.5

(-21.46%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

196.46K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$1.42 L

$12.75 H

$1.83

About Baird Medical Investment Holdings Limited, Common Stock

Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China. more

Returns

Data is not properly formatted.

Time Frame	BDMD		S&P500
1-Week Return	18.06%%	%	-3%%
1-Month Return	-25.91%%	%	-0.73%%
3-Month Return	-84.03%%	%	2.87%%

Financials

	Dec '21	Dec '22	Dec '23
Total Revenue	27.72M	35.09M	31.46M	[{"date":"2021-12-31","value":79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.65,"profit":true}]
Cost of Revenue	4.54M	7.05M	4.23M	[{"date":"2021-12-31","value":64.42,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":59.93,"profit":true}]
Gross Profit	23.18M	28.04M	27.23M	[{"date":"2021-12-31","value":82.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.12,"profit":true}]
Gross Margin	83.61%	79.90%	86.56%	[{"date":"2021-12-31","value":96.59,"profit":true},{"date":"2022-12-31","value":92.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	14.63M	20.08M	18.80M	[{"date":"2021-12-31","value":72.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.63,"profit":true}]
Operating Income	13.09M	15.01M	12.65M	[{"date":"2021-12-31","value":87.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":84.32,"profit":true}]
Total Non-Operating Income/Expense	(486.67K)	(485.30K)	(294.48K)	[{"date":"2021-12-31","value":-48667000,"profit":false},{"date":"2022-12-31","value":-48529600,"profit":false},{"date":"2023-12-31","value":-29448200,"profit":false}]
Pre-Tax Income	12.61M	14.52M	12.36M	[{"date":"2021-12-31","value":86.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":85.11,"profit":true}]
Income Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	10.18M	12.77M	10.66M	[{"date":"2021-12-31","value":79.71,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.43,"profit":true}]
Income From Discontinued Operations	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	10.09M	12.57M	10.55M	[{"date":"2021-12-31","value":80.27,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.91,"profit":true}]

EPS (Diluted)	(0.02)	0.02	(0.36)	[{"date":"2021-12-31","value":-74.65,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1652.53,"profit":false}]

	Dec '21	Dec '22	Dec '23
Total Revenue	-	26.58%	(10.35%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-38.95,"profit":false}]
Cost of Revenue	-	55.24%	(40.07%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-72.55,"profit":false}]
Gross Profit	-	20.96%	(2.88%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-13.72,"profit":false}]
Gross Margin	-	(4.44%)	8.34%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-53.21,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	37.28%	(6.37%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.09,"profit":false}]
Operating Income	-	14.63%	(15.68%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-107.22,"profit":false}]
Total Non-Operating Income/Expense	-	(0.28%)	(39.32%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Pre-Tax Income	-	15.20%	(14.89%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-97.97,"profit":false}]
Income Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	25.45%	(16.57%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-65.1,"profit":false}]
Income From Discontinued Operations	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	24.58%	(16.09%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-65.48,"profit":false}]

EPS (Diluted)	-	(233.95%)	(1752.53%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '21	Dec '22	Dec '23
Total Assets
Current Assets	21.45M	33.76M	40.08M	[{"date":"2021-12-31","value":53.51,"profit":true},{"date":"2022-12-31","value":84.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	3.83M	8.85M	16.63M	[{"date":"2021-12-31","value":23.05,"profit":true},{"date":"2022-12-31","value":53.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	25.28M	42.62M	56.71M	[{"date":"2021-12-31","value":44.58,"profit":true},{"date":"2022-12-31","value":75.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	9.77M	16.02M	18.98M	[{"date":"2021-12-31","value":51.46,"profit":true},{"date":"2022-12-31","value":84.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	494.12K	816.88K	2.03M	[{"date":"2021-12-31","value":24.39,"profit":true},{"date":"2022-12-31","value":40.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	10.26M	16.84M	21.00M	[{"date":"2021-12-31","value":48.85,"profit":true},{"date":"2022-12-31","value":80.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(6.78M)	3.96M	14.39M	[{"date":"2021-12-31","value":-47.09,"profit":false},{"date":"2022-12-31","value":27.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	15.38M	25.93M	35.75M	[{"date":"2021-12-31","value":43.01,"profit":true},{"date":"2022-12-31","value":72.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	25.64M	42.77M	56.75M	[{"date":"2021-12-31","value":45.17,"profit":true},{"date":"2022-12-31","value":75.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23
Total Assets
Current Assets	-	57.40%	18.72%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":32.6,"profit":true}]
Non-current Assets	-	131.00%	87.78%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":67.01,"profit":true}]
Total Assets	-	68.56%	33.06%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":48.22,"profit":true}]

Total Liabilities
Current Liabilities	-	64.08%	18.43%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.75,"profit":true}]
Non-current Liabilities	-	65.32%	147.98%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":44.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	64.14%	24.71%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":38.52,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	(158.44%)	263.38%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-60.16,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	68.65%	37.86%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":55.15,"profit":true}]

Total Liabilities & Shareholders Equity	-	66.84%	32.68%	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":48.89,"profit":true}]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]


Total Assets
Current Assets	[]
Non-current Assets	[]
Total Assets	[]

Total Liabilities
Current Liabilities	[]
Non-current Liabilities	[]
Total Liabilities	[]

Total Shareholders' equity
Common Stock	[]
Retained Earnings	[]
Other Stockholders' Equity	[]
Total Shareholders' equity	[]

Total Liabilities & Shareholders Equity	[]

	Dec '21	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	5.26M	485.97K	(1.02M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.25,"profit":true},{"date":"2023-12-31","value":-19.41,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(1.93M)	4.41M	3.46M	[{"date":"2021-12-31","value":-43.66,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":78.45,"profit":true}]

Net Change in Cash	1.96M	(1.32M)	(200.44K)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-67.4,"profit":false},{"date":"2023-12-31","value":-10.22,"profit":false}]

Free Cash Flow
Free Cash Flow	3.87M	(5.47M)	(3.66M)	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-141.39,"profit":false},{"date":"2023-12-31","value":-94.6,"profit":false}]

	Dec '21	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	(90.75%)	(309.88%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	(329.05%)	(21.55%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Net Change in Cash	-	(167.40%)	(84.83%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(241.39%)	(33.10%)	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BDMD
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BDMD
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Baird Medical Investment Holdings Limited share price today?

Baird Medical Investment Holdings Limited (BDMD) share price today is $1.83

Can Indians buy Baird Medical Investment Holdings Limited shares?

Yes, Indians can buy shares of Baird Medical Investment Holdings Limited (BDMD) on Vested. To buy Baird Medical Investment Holdings Limited from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BDMD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Baird Medical Investment Holdings Limited be purchased?

Yes, you can purchase fractional shares of Baird Medical Investment Holdings Limited (BDMD) via the Vested app. You can start investing in Baird Medical Investment Holdings Limited (BDMD) with a minimum investment of $1.

How to invest in Baird Medical Investment Holdings Limited shares from India?

You can invest in shares of Baird Medical Investment Holdings Limited (BDMD) via Vested in three simple steps:

Click on Sign Up or Invest in BDMD stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Baird Medical Investment Holdings Limited shares

What is Baird Medical Investment Holdings Limited 52-week high and low stock price?

The 52-week high price of Baird Medical Investment Holdings Limited (BDMD) is $12.75. The 52-week low price of Baird Medical Investment Holdings Limited (BDMD) is $1.42.

What is Baird Medical Investment Holdings Limited price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Baird Medical Investment Holdings Limited (BDMD) is

What is Baird Medical Investment Holdings Limited price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Baird Medical Investment Holdings Limited (BDMD) is 0.00

What is Baird Medical Investment Holdings Limited dividend yield?

The dividend yield of Baird Medical Investment Holdings Limited (BDMD) is 0.00%

What is the Market Cap of Baird Medical Investment Holdings Limited?

The market capitalization of Baird Medical Investment Holdings Limited (BDMD) is

What is Baird Medical Investment Holdings Limited’s stock symbol?

The stock symbol (or ticker) of Baird Medical Investment Holdings Limited is BDMD